I Don’t Want to Shoot up the Meth Anymore
Pipe Distribution as a Harm Reduction Service for People Who Use Methamphetamine
Bibliographic Data
BACKGROUND: Methamphetamine use is disproportionately high in rural settings, with rates increasing during the COVID-19 pandemic. While syringe service programs reduce disease transmission among people who inject drugs, limited research exists around the value of smoking equipment, specifically pipes, in minimizing harms associated with rural methamphetamine use. METHODS: We conducted semi-structured interviews with people who use methamphetamine in rural southern Illinois. Inclusion criteria involved methamphetamine use in the past 30 days. Interview guides explored attitudes and behaviors regarding pipe use practices and pipe access. Interviews were recorded, transcribed, and coded. The data were analyzed for emergent themes using a sequential, deductive process. RESULTS: Nineteen participants, average age 37.1 (SD + 8.7), were interviewed. 53% were women, and 89% were white. All reported smoking methamphetamine, and 84% reported injecting. Participants reported engaging in smoking instead of injection to decrease wounds, pain, and infections. Smoking enabled some to use socially as opposed to alone, as was typically the case when they injected. Participants expressed interest in pipe distribution through a harm reduction agency. They shared that, were a harm reduction agency to distribute pipes, it would connect people to other services such as HIV testing, naloxone, and safer sex supplies. CONCLUSIONS: Pipe distribution may function as a harm reduction strategy by decreasing injection and solitary drug use and linking patients to additional services. Given disproportionate methamphetamine use in rural regions, this intervention could specifically address drug-related harms that impact rural populations
Business · Disease · Environmental health · Harm · Harm reduction · Medical emergency · Meth · Methamphetamine · Pandemic · Psychiatry · Syringe · Forensic Toxicology and Drug Analysis · HIV, Drug Use, Sexual Risk · Medicine · Opioid Use Disorder Treatment · Psychology · Social Psychology · Marketing · Virology
HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015
Challenges posed by Covid‐19 to people who inject drugs and lessons from other outbreaks
Harm reduction
Fostering implementation of health services research findings into practice
Consolidated criteria for reporting qualitative research (Coreq)
Social and Environmental Factors and Their Influence on Drug Use Vulnerability and Resiliency in Rural Populations
The Impact of the Covid-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings
Identifying Areas with Disproportionate Local Health Department Services Relative to Opioid Overdose, HIV and Hepatitis C Diagnosis Rates
Harm reduction as anarchist practice
Preventing transitions into injection drug use
Opioid overdose reversals using naloxone in New York City by people who use opioids
Guidelines for better harm reduction
Increased solitary drug use during Covid-19
I inject less as I have easier access to pipes”
Harm reduction through a social justice lens
State-Level History of Overdose Deaths Involving Stimulants in the United States, 1999‒2020
The Constant Comparative Method of Qualitative Analysis
| Unique citing works | 1 |
|---|---|
| Citations per year | 1 |
| Citation span | 2025 - 2025 (1) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 1 |